Appili Raises $2.2M in Equity Funding

Halifax-based Appili Therapeutics Inc., whose ultimate goal is to produce a drug that treats superbugs, has closed a $2.15-million equity funding round to help fund clinical trials for its first product.
The company said in a press release the funding came from existing and new investors, including a contribution from Innovacorp, which participated in its last funding round. The company in 2015